The adenomyosis market is expected to register a CAGR of 4.5% during the forecast period, 2018–2023. The global adenomyosis market is majorly driven by the high prevalence of urinary tract infections, rise in fibroid removal surgeries, increasing infection rates, rising population of women aged 40 and above, rising demand for technical advancements, increasing number of regulatory approvals, and growing penetration by market players. Additionally, factors such as the increasing funding for research and development initiatives in advanced medical treatment options are likely to drive the market. However, factors such as lack of awareness regarding causes and symptoms of adenomyosis are likely to hamper the growth of the market.
Market Segmentation
The global adenomyosis market is segmented on the basis of type, treatment, diagnosis, and end-user. Considering type, the market is segmented into focal, adenomyoma, and diffuse. With reference to treatment, the market is segmented into anti-inflammatory drugs, hormone medications, and hysterectomy. By anti-inflammatory drugs, the market is sub-segmented into ibuprofen and naproxen. By hormone medications, the market is segmented into combined estrogen-progestin pills, vaginal rings, hormone-containing patches, and aromatase inhibitors. Based on diagnosis, the market is segmented into ultrasound, MRI, historiography, hysteroscopy, cystoscopy, and laparoscopy. By end-user, the market is segmented into hospitals and clinics, research institutes and ambulatory surgical centers, and others. Based on region, the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Research Methodology:
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Market Segmentation & Key players
Adenomyosis Market, by Type
- Focal Physiotherapy
- Adenomyoma
- Diffuse
Adenomyosis Market, by Treatment
- Anti-Inflammatory Drugs
- Ibuprofen
- Naproxen
- Hormone Medications
- Combined estrogen-progestin pills
- Vaginal rings
- Hormone-containing patches
- Aromatase inhibitors
- Hysterectomy
Adenomyosis Market, by Diagnosis
- Ultrasound
- MRI
- Historiography
- Hysteroscopy
- Cystoscopy
- Laparoscopy
Adenomyosis Market, by End-user
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization